Literature DB >> 1381590

CSF monoamine metabolites in old age dementias.

L Parnetti1, A Gaiti, G P Reboldi, C Santucci, P Mecocci, M Brunetti, D Cadini, U Senin.   

Abstract

Cerebrospinal Fluid (CSF) levels of the main metabolites of monoamines (MHPG, 5-HIAA, and HVA) were measured in patients with early onset (AD) and late-onset (SDAT) Alzheimer's disease, vascular dementia (VD), and elderly controls. Psychobehavioral assessment was carried out by means of MMSE and GBS. Mean MHPG levels did not differ from controls; 5-HIAA was lower in VD when compared to both controls and SDAT. HVA was decreased in AD, SDAT, and VD with respect to controls. Significant correlations between HVA and psycho-behavioral parameters were observed in SDAT and VD groups, whereas no relationship was documented in AD. The SDAT group was divided in SDAT-A (age at onset: greater than 65 less than or equal to 80 yr) and SDAT-B (age at onset: greater than 80 yr). SDAT-A had significantly lower CSF HVA values than SDAT-B (165 +/- 64 vs 235.7 +/- 85). SDAT-B HVA levels were similar to those observed in controls. Correlation analysis between HVA and neuropsychological variables was significant in SDAT-A, but not in SDAT-B. These results might support the evidence of SDAT heterogeneity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1381590     DOI: 10.1007/bf03159966

Source DB:  PubMed          Journal:  Mol Chem Neuropathol        ISSN: 1044-7393


  3 in total

1.  Effect of oral administration of zanapezil (TAK-147) for 21 days on acetylcholine and monoamines levels in the ventral hippocampus of freely moving rats.

Authors:  Izzettin Hatip-Al-Khatib; Katsunori Iwasaki; Yoshitaka Yoshimitsu; Takashi Arai; Nobuaki Egashira; Kenichi Mishima; Tomoaki Ikeda; Michihiro Fujiwara
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

Review 2.  Monoaminergic neuropathology in Alzheimer's disease.

Authors:  Goran Šimić; Mirjana Babić Leko; Selina Wray; Charles R Harrington; Ivana Delalle; Nataša Jovanov-Milošević; Danira Bažadona; Luc Buée; Rohan de Silva; Giuseppe Di Giovanni; Claude M Wischik; Patrick R Hof
Journal:  Prog Neurobiol       Date:  2016-04-12       Impact factor: 11.685

3.  Cerebrospinal fluid catecholamines in Alzheimer's disease patients with and without biological disease.

Authors:  Kristi Henjum; Leiv Otto Watne; Kristin Godang; Nathalie Bodd Halaas; Rannveig Saksholm Eldholm; Kaj Blennow; Henrik Zetterberg; Ingvild Saltvedt; Jens Bollerslev; Anne Brita Knapskog
Journal:  Transl Psychiatry       Date:  2022-04-09       Impact factor: 6.222

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.